Kalyani group sets up Institute for Prostrate Cancer

Our Bureau Pune | Updated on November 20, 2017 Published on January 11, 2012

The Kalyani group has set up a state-of-the-art facility for the diagnostics, treatment and research of prostrate cancer at Pune in association with Ruby Hall Clinic. The Institute for Prostate Cancer will be established and supported by Dr Ashutosh Tewari, an American urologist and oncologist.

Mr Baba Kalyani, promoter of the Institute and Chairman, Kalyani Group said, “Prostate cancer today is the second largest cause of death in males after lung cancer. Our endeavour is to create awareness about this potentially lethal disease and focus on research, early diagnosis and treatment.”

The Institute will have five distinct priority areas that will address screening and treatment, prostate cancer genomics, imaging and education.

“We will use an integrated team approach for both treatment and research. The Institute will bring together biologists, genome scientists, physicians, engineers, and computer scientists. We will build collaborations with a broader community of researchers and clinicians worldwide to help cure prostate cancer,” Dr Ashutosh Tewari said.

Published on January 11, 2012
This article is closed for comments.
Please Email the Editor